Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases

[1]  E. Calle,et al.  Doctors and climate change , 2007, BMJ : British Medical Journal.

[2]  W. Jiang,et al.  Hepatocyte growth factor activation inhibitors (HAI‐1 and HAI‐2) regulate HGF‐induced invasion of human breast cancer cells , 2006, International journal of cancer.

[3]  M. Bouxsein,et al.  Combined treatment with a beta-blocker and intermittent PTH improves bone mass and microarchitecture in ovariectomized mice. , 2006, Bone.

[4]  Joyce Curvers,et al.  Effects of storage‐induced platelet microparticles on the initiation and propagation phase of blood coagulation , 2006, British journal of haematology.

[5]  H. Shim,et al.  Lower expression of CXCR4 in lymph node metastases than in primary breast cancers: potential regulation by ligand-dependent degradation and HIF-1alpha. , 2006, Biochemical and biophysical research communications.

[6]  M. Reiss,et al.  Inhibition of Growth and Metastasis of Mouse Mammary Carcinoma by Selective Inhibitor of Transforming Growth Factor-β Type I Receptor Kinase In vivo , 2006, Clinical Cancer Research.

[7]  Kathryn E Luker,et al.  Functions of CXCL12 and CXCR4 in breast cancer. , 2006, Cancer letters.

[8]  J. Chirgwin,et al.  New insights into the role of T cells in the vicious cycle of bone metastases , 2006, Current opinion in rheumatology.

[9]  Xiu-fen Lei,et al.  Inhibition of pulmonary and skeletal metastasis by a transforming growth factor-beta type I receptor kinase inhibitor. , 2006, Cancer research.

[10]  D. Fabbro,et al.  Inhibition of Protein Kinase c-Src Reduces the Incidence of Breast Cancer Metastases and Increases Survival in Mice: Implications for Therapy , 2006, Journal of Pharmacology and Experimental Therapeutics.

[11]  E. Feldman,et al.  Insulin-like growth factor-I receptor expression regulates neuroblastoma metastasis to bone. , 2006, Cancer research.

[12]  P. Clézardin,et al.  The type 1 lysophosphatidic acid receptor is a target for therapy in bone metastases. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[13]  X. Pei,et al.  [Expression of angiogenesis-related factors in invasive breast cancer and its clinical significance]. , 2006, Nan fang yi ke da xue xue bao = Journal of Southern Medical University.

[14]  J. Rubin,et al.  IGF‐I secretion by prostate carcinoma cells does not alter tumor‐bone cell interactions in vitro or in vivo , 2006, The Prostate.

[15]  A. Baccarelli,et al.  The role of CXCR4 receptor expression in breast cancer: a large tissue microarray study , 2006, Breast Cancer Research and Treatment.

[16]  G. Strewler.  The stem cell niche and bone metastasis , 2006 .

[17]  P. Härkönen,et al.  Regulation of osteoblast differentiation: a novel function for fibroblast growth factor 8. , 2006, Endocrinology.

[18]  E. Canalis,et al.  Expression and regulation of CCN genes in murine osteoblasts. , 2006, Bone.

[19]  V. Cerundolo,et al.  Malignant melanoma and bone resorption , 2006, British Journal of Cancer.

[20]  Robin L. Anderson,et al.  Tumor-specific expression of αvβ3 integrin promotes spontaneous metastasis of breast cancer to bone , 2006, Breast Cancer Research.

[21]  K. Roy,et al.  The HIV entry inhibitors revisited. , 2006, Current medicinal chemistry.

[22]  A. Friedl,et al.  Syndecan-1 expression by stromal fibroblasts promotes breast carcinoma growth in vivo and stimulates tumor angiogenesis , 2006, Oncogene.

[23]  David C. Smith,et al.  Phase II evaluations of cilengitide in asymptomatic patients with androgen-independent prostate cancer: scientific rationale and study design. , 2006, Clinical genitourinary cancer.

[24]  R. Graham,et al.  Tumor-derived Cyr61(CCN1) promotes stromal matrix metalloproteinase-1 production and protease-activated receptor 1-dependent migration of breast cancer cells. , 2006, Cancer research.

[25]  R. Pacifici,et al.  The role of T lymphocytes in bone metabolism , 2005, Immunological reviews.

[26]  J. Chirgwin,et al.  Tumor-derived interleukin-8 stimulates osteolysis independent of the receptor activator of nuclear factor-kappaB ligand pathway. , 2005, Cancer research.

[27]  D. Fox,et al.  Immunocompetent Properties of Human Osteoblasts: Interactions With T Lymphocytes , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  G. Clines,et al.  Hypercalcaemia of malignancy and basic research on mechanisms responsible for osteolytic and osteoblastic metastasis to bone. , 2005, Endocrine-related cancer.

[29]  M. Chávez-MacGregor,et al.  Angiogenesis in the Bone Marrow of Patients with Breast Cancer , 2005, Clinical Cancer Research.

[30]  Horst Buerger,et al.  First evidence supporting a potential role for the BMP/SMAD pathway in the progression of oestrogen receptor‐positive breast cancer , 2005, The Journal of pathology.

[31]  T. Guise,et al.  Breast Cancer Metastasis to Bone: Mechanisms of Osteolysis and Implications for Therapy , 2005, Journal of Mammary Gland Biology and Neoplasia.

[32]  D. Ornitz,et al.  FGF signaling in the developing endochondral skeleton. , 2005, Cytokine & growth factor reviews.

[33]  T. Yoneda,et al.  Crosstalk between cancer cells and bone microenvironment in bone metastasis. , 2005, Biochemical and biophysical research communications.

[34]  H. Shimada,et al.  Bone marrow mesenchymal stem cells provide an alternate pathway of osteoclast activation and bone destruction by cancer cells. , 2005, Cancer research.

[35]  J. Chirgwin,et al.  Molecular mechanisms of breast cancer metastases to bone. , 2005, Clinical breast cancer.

[36]  J. Votaw,et al.  Silencing of CXCR4 blocks breast cancer metastasis. , 2005, Cancer research.

[37]  S. Colucci,et al.  Mechanisms of spontaneous osteoclastogenesis in cancer with bone involvement , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  P. Clézardin,et al.  Platelet-derived lysophosphatidic acid supports the progression of osteolytic bone metastases in breast cancer. , 2004, The Journal of clinical investigation.

[39]  Abraham Schneider,et al.  Skeletal Localization and Neutralization of the SDF‐1(CXCL12)/CXCR4 Axis Blocks Prostate Cancer Metastasis and Growth in Osseous Sites In Vivo , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[40]  K. Pantel,et al.  Bone marrow micrometastases and circulating tumor cells: current aspects and future perspectives , 2004, Breast Cancer Research.

[41]  K. Shitara,et al.  Growth Inhibition of Human Prostate Cancer Cells in Human Adult Bone Implanted into Nonobese Diabetic/Severe Combined Immunodeficient Mice by a Ligand-Specific Antibody to Human Insulin-Like Growth Factors , 2004, Cancer Research.

[42]  J. Chirgwin,et al.  Tumor-bone cellular interactions in skeletal metastases. , 2004, Journal of musculoskeletal & neuronal interactions.

[43]  D. Griggs,et al.  A small molecule antagonist of the αvβ3 integrin suppresses MDA-MB-435 skeletal metastasis , 2004, Clinical & Experimental Metastasis.

[44]  S. Nie,et al.  Inhibition of Breast Cancer Metastasis by Selective Synthetic Polypeptide against CXCR4 , 2004, Cancer Research.

[45]  Ruud H. Brakenhoff,et al.  Dissecting the metastatic cascade , 2004, Nature Reviews Cancer.

[46]  A. Harris,et al.  Bone morphogenetic protein 2 (BMP-2) induces in vitro invasion and in vivo hormone independent growth of breast carcinoma cells. , 2004, International journal of oncology.

[47]  T. Libermann,et al.  Inhibition of the insulin-like growth factor receptor-1 tyrosine kinase activity as a therapeutic strategy for multiple myeloma, other hematologic malignancies, and solid tumors. , 2004, Cancer cell.

[48]  D. Mcfadden,et al.  Leptin is a growth factor in cancer. , 2004, The Journal of surgical research.

[49]  A. Friedl,et al.  Induction of Syndecan-1 Expression in Stromal Fibroblasts Promotes Proliferation of Human Breast Cancer Cells , 2004, Cancer Research.

[50]  D. Scadden,et al.  Osteoblastic cells regulate the haematopoietic stem cell niche , 2003, Nature.

[51]  G. Semenza.  Targeting HIF-1 for cancer therapy , 2003, Nature Reviews Cancer.

[52]  S. Toda,et al.  Mature adipocytes, but not preadipocytes, promote the growth of breast carcinoma cells in collagen gel matrix culture through cancer–stromal cell interactions , 2003, The Journal of pathology.

[53]  L. Claes,et al.  IL-6 and PGE2 release by human osteoblasts on implant materials. , 2003, Biomaterials.

[54]  Puneeth Iyengar,et al.  Adipocyte-secreted factors synergistically promote mammary tumorigenesis through induction of anti-apoptotic transcriptional programs and proto-oncogene stabilization , 2003, Oncogene.

[55]  R. Bohacek,et al.  Novel bone-targeted Src tyrosine kinase inhibitor drug discovery. , 2003, Current opinion in drug discovery & development.

[56]  J. Chirgwin,et al.  A causal role for endothelin-1 in the pathogenesis of osteoblastic bone metastases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[57]  Paul J. Williams,et al.  C-SRC tyrosine kinase activity is associated with tumor colonization in bone and lung in an animal model of human breast cancer metastasis. , 2003, Cancer research.

[58]  C. Cordon-Cardo,et al.  A multigenic program mediating breast cancer metastasis to bone. , 2003, Cancer cell.

[59]  I. Fidler,et al.  The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited , 2003, Nature Reviews Cancer.

[60]  D. Griggs,et al.  The angiogenic factor CYR61 in breast cancer: molecular pathology and therapeutic perspectives. , 2003, Endocrine-related cancer.

[61]  I. Reid,et al.  Adrenomedullin—a regulator of bone formation , 2003, Regulatory Peptides.

[62]  S. Morrison,et al.  Prospective identification of tumorigenic breast cancer cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[63]  A. Blais,et al.  Overexpression of a dominant negative type II bone morphogenetic protein receptor inhibits the growth of human breast cancer cells. , 2003, Cancer research.

[64]  Carlos López-Otín,et al.  Strategies for MMP inhibition in cancer: innovations for the post-trial era , 2002, Nature Reviews Cancer.

[65]  R. Anderson,et al.  Genes involved in breast cancer metastasis to bone , 2002, Cellular and Molecular Life Sciences CMLS.

[66]  A. Moursi,et al.  Fibroblast Growth Factor 2 Induces Increased Calvarial Osteoblast Proliferation and Cranial Suture Fusion , 2002 .

[67]  E. Nemeth,et al.  The search for calcium receptor antagonists (calcilytics). , 2002, Journal of molecular endocrinology.

[68]  J. Chirgwin,et al.  Transforming Growth Factor-β Stimulates Parathyroid Hormone-related Protein and Osteolytic Metastases via Smad and Mitogen-activated Protein Kinase Signaling Pathways* , 2002, The Journal of Biological Chemistry.

[69]  L. Wakefield,et al.  Lifetime exposure to a soluble TGF-beta antagonist protects mice against metastasis without adverse side effects. , 2002, The Journal of clinical investigation.

[70]  C. Arteaga,et al.  Blockade of TGF-β inhibits mammary tumor cell viability, migration, and metastases , 2002 .

[71]  Lynda F. Bonewald,et al.  Proteolysis of Latent Transforming Growth Factor-β (TGF-β)-binding Protein-1 by Osteoclasts , 2002, The Journal of Biological Chemistry.

[72]  M. Crépin,et al.  FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. , 2002, Biochemical and biophysical research communications.

[73]  M. Oehler,et al.  Adrenomedullin promotes formation of xenografted endometrial tumors by stimulation of autocrine growth and angiogenesis , 2002, Oncogene.

[74]  B. Fingleton,et al.  Matrix Metalloproteinase Inhibitors and Cancer—Trials and Tribulations , 2002, Science.

[75]  Paul J. Williams,et al.  Tumor-derived platelet-derived growth factor-BB plays a critical role in osteosclerotic bone metastasis in an animal model of human breast cancer. , 2002, Cancer research.

[76]  L. Wakefield,et al.  TGF-β signaling: positive and negative effects on tumorigenesis , 2002 .

[77]  Yudong D. He,et al.  Gene expression profiling predicts clinical outcome of breast cancer , 2002, Nature.

[78]  Kozo Nakamura,et al.  Regulation of Osteoclast Differentiation by Fibroblast Growth Factor 2: Stimulation of Receptor Activator of Nuclear Factor κB Ligand/Osteoclast Differentiation Factor Expression in Osteoblasts and Inhibition of Macrophage Colony‐Stimulating Factor Function in Osteoclast Precursors , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[79]  A. Nerlich,et al.  Matrix metalloproteinases (MMPs) in breast cancer cell lines of different tumorigenicity. , 2001, Anticancer research.

[80]  C. Haudenschild,et al.  Cortactin potentiates bone metastasis of breast cancer cells. , 2001, Cancer research.

[81]  Paul J. Williams,et al.  A Bone‐Seeking Clone Exhibits Different Biological Properties from the MDA‐MB‐231 Parental Human Breast Cancer Cells and a Brain‐Seeking Clone In Vivo and In Vitro , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[82]  H. Vloedgraven,et al.  Monitoring Metastatic Behavior of Human Tumor Cells in Mice with Species‐Specific Polymerase Chain Reaction: Elevated Expression of Angiogenesis and Bone Resorption Stimulators by Breast Cancer in Bone Metastases , 2001, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[83]  P. Kostenuik,et al.  Osteoprotegerin: a physiological and pharmacological inhibitor of bone resorption. , 2001, Current pharmaceutical design.

[84]  E. Canalis,et al.  The Metastasis-Associated Metalloproteinase Stromelysin-3 Is Induced by Transforming Growth Factor-β in Osteoblasts and Fibroblasts. , 2001, Endocrinology.

[85]  T. Mcclanahan,et al.  Involvement of chemokine receptors in breast cancer metastasis , 2001, Nature.

[86]  J W Smith,et al.  Integrin activation controls metastasis in human breast cancer. , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[87]  J. Hopper,et al.  Parathyroid hormone-related protein production by breast cancers, improved survival, and reduced bone metastases. , 2001, Journal of the National Cancer Institute.

[88]  R. Taichman,et al.  Hepatocyte growth factor is secreted by osteoblasts and cooperatively permits the survival of haematopoietic progenitors , 2001, British journal of haematology.

[89]  E. Brown,et al.  Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines. , 2000, Endocrinology.

[90]  A. Celeste,et al.  Bone morphogenetic protein-2 induces cyclin kinase inhibitor p21 and hypophosphorylation of retinoblastoma protein in estradiol-treated MCF-7 human breast cancer cells. , 2000, Biochimica et biophysica acta.

[91]  P. Delmas,et al.  Influence of mature adipocytes on osteoblast proliferation in human primary cocultures. , 2000, Bone.

[92]  Stuart A. Aaronson,et al.  Exogenous Expression of N-Cadherin in Breast Cancer Cells Induces Cell Migration, Invasion, and Metastasis , 2000, The Journal of cell biology.

[93]  S. F. Arnold,et al.  Identification of bone morphogenetic proteins and their receptors in human breast cancer cell lines: importance of BMP2. , 1999, Cytokine.

[94]  T. Martin,et al.  Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation1. , 1999, Endocrinology.

[95]  T. Yoneda,et al.  Factors regulating the growth of metastatic cancer in bone. , 1999, Endocrine-related cancer.

[96]  S. Maeda,et al.  Evidence for stanniocalcin gene expression in mammalian bone. , 1999, Endocrinology.

[97]  M. Jensen,et al.  Leptin acts on human marrow stromal cells to enhance differentiation to osteoblasts and to inhibit differentiation to adipocytes. , 1999, Endocrinology.

[98]  S. Krane,et al.  Bone resorption induced by parathyroid hormone is strikingly diminished in collagenase-resistant mutant mice. , 1999, The Journal of clinical investigation.

[99]  R Wieser,et al.  TGF-beta signaling blockade inhibits PTHrP secretion by breast cancer cells and bone metastases development. , 1999, The Journal of clinical investigation.

[100]  M. Kondo,et al.  The expression and localization of fibroblast growth factor-1 (FGF-1) and FGF receptor-1 (FGFR-1) in human breast cancer. , 1998, Clinical immunology and immunopathology.

[101]  R. Coleman.  Skeletal complications of malignancy , 1997, Cancer.

[102]  G Shimamoto,et al.  Osteoprotegerin: A Novel Secreted Protein Involved in the Regulation of Bone Density , 1997, Cell.

[103]  B F Boyce,et al.  Evidence for a causal role of parathyroid hormone-related protein in the pathogenesis of human breast cancer-mediated osteolysis. , 1996, The Journal of clinical investigation.

[104]  T. Yoneda,et al.  E-cadherin expression in human breast cancer cells suppresses the development of osteolytic bone metastases in an experimental metastasis model. , 1996, Cancer research.

[105]  S. Kitazawa,et al.  Integrin alpha V beta 3 expression by bone-residing breast cancer metastases. , 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[106]  S. Kitazawa,et al.  Integrin αvβ3 Expression by Bone‐residing Breast Cancer Metastases , 1996 .

[107]  A. Wetterwald,et al.  Synthesis of membrane‐ and matrix‐bound colony‐stimulating factor‐1 by cultured osteoblasts , 1996, Journal of cellular physiology.

[108]  N. Franchimont,et al.  Platelet-derived growth factor stimulates the synthesis of interleukin-6 in cells of the osteoblast lineage. , 1995, Endocrinology.

[109]  G. Roodman,et al.  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo. , 1995, The Journal of clinical investigation.

[110]  S. Rodan,et al.  Induction of vascular endothelial growth factor expression by prostaglandin E2 and E1 in osteoblasts. , 1994, The Journal of clinical investigation.

[111]  G. Powell,et al.  Localization of parathyroid hormone‐related protein mrna expression in breast cancer and metastatic lesions by in situ hybridization , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[112]  J. Wozney,et al.  The bone morphogenetic protein family and osteogenesis , 1992, Molecular reproduction and development.

[113]  B. Elliott,et al.  Capacity of adipose tissue to promote growth and metastasis of a murine mammary carcinoma: Effect of estrogen and progesterone , 1992, International journal of cancer.

[114]  L. Weiss.  Comments on hematogenous metastatic patterns in humans as revealed by autopsy , 1992, Clinical & Experimental Metastasis.

[115]  M. Freeman,et al.  Expression cloning of a common receptor for parathyroid hormone and parathyroid hormone-related peptide from rat osteoblast-like cells: a single receptor stimulates intracellular accumulation of both cAMP and inositol trisphosphates and increases intracellular free calcium. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[116]  J. Hayman,et al.  Localization of parathyroid hormone-related protein in breast cancer metastases: increased incidence in bone compared with other sites. , 1991, Cancer research.

[117]  J. Hayman,et al.  Immunohistochemical localization of parathyroid hormone-related protein in human breast cancer. , 1990, Cancer research.

[118]  L. Avioli,et al.  Human osteoblasts in vitro secrete tissue inhibitor of metalloproteinases and gelatinase but not interstitial collagenase as major cellular products. , 1989, The Journal of clinical investigation.

[119]  I A Silver,et al.  Microelectrode studies on the acid microenvironment beneath adherent macrophages and osteoclasts. , 1988, Experimental cell research.

[120]  R. Rubens,et al.  The clinical course of bone metastases from breast cancer. , 1987, British Journal of Cancer.

[121]  M. Klagsbrun,et al.  Growth factors in bone matrix. Isolation of multiple types by affinity chromatography on heparin-Sepharose. , 1986, The Journal of biological chemistry.

[122]  R. Custer,et al.  A severe combined immunodeficiency mutation in the mouse , 1983, Nature.

[123]  S Paget,et al.  THE DISTRIBUTION OF SECONDARY GROWTHS IN CANCER OF THE BREAST. , 1889 .

[124]  R. Taichman,et al.  The role of osteoblasts in regulating hematopoietic stem cell activity and tumor metastasis. , 2005, Brazilian journal of medical and biological research = Revista brasileira de pesquisas medicas e biologicas.

[125]  T. Partridge,et al.  Nude mutation influences limb skeletal muscle development. , 2005, Matrix biology : journal of the International Society for Matrix Biology.

[126]  G. Spalluto,et al.  Non peptidic alphavbeta3 antagonists: recent developments. , 2005, Current medicinal chemistry.

[127]  J. Degen,et al.  Platelets and fibrin(ogen) increase metastatic potential by impeding natural killer cell-mediated elimination of tumor cells. , 2005, Blood.

[128]  D. Nam,et al.  Inhibition of platelet-derived growth factor receptor signaling restricts the growth of human breast cancer in the bone of nude mice. , 2005, Clinical cancer research : an official journal of the American Association for Cancer Research.

[129]  G. Spalluto,et al.  Non Peptidic αvβ3 Antagonists: Recent Developments , 2005 .

[130]  D. Griggs,et al.  A small molecule antagonist of the alpha(v)beta3 integrin suppresses MDA-MB-435 skeletal metastasis. , 2004, Clinical & experimental metastasis.

[131]  L. Seymour,et al.  Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer , 2004, Breast Cancer Research and Treatment.

[132]  L. Seymour,et al.  Tissue platelet derived-growth factor (PDGF) predicts for shortened survival and treatment failure in advanced breast cancer , 2004, Breast Cancer Research and Treatment.

[133]  L. Nakopoulou,et al.  MMP-2 Protein in Invasive Breast Cancer and the Impact of MMP-2/TIMP-2 Phenotype on Overall Survival , 2004, Breast Cancer Research and Treatment.

[134]  P. Okunieff,et al.  Fibroblast growth factors (FGFS) increase breast tumor growth rate, metastases, blood flow, and oxygenation without significant change in vascular density. , 2003, Advances in experimental medicine and biology.

[135]  J. Massagué,et al.  Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer. , 2003, Nature reviews. Cancer.

[136]  C. Arteaga,et al.  Blockade of TGF-beta inhibits mammary tumor cell viability, migration, and metastases. , 2002, The Journal of clinical investigation.

[137]  C. Overall,et al.  Cancer cell-associated fibronectin induces release of matrix metalloproteinase-2 from normal fibroblasts. , 2002, Cancer research.

[138]  L. Wakefield,et al.  TGF-beta signaling: positive and negative effects on tumorigenesis. , 2002, Current opinion in genetics & development.

[139]  Sarah L Dallas,et al.  Proteolysis of latent transforming growth factor-beta (TGF-beta )-binding protein-1 by osteoclasts. A cellular mechanism for release of TGF-beta from bone matrix. , 2002, The Journal of biological chemistry.

[140]  E. Canalis,et al.  The metastasis-associated metalloproteinase stromelysin-3 is induced by transforming growth factor-beta in osteoblasts and fibroblasts. , 2001, Endocrinology.

[141]  J. Pickren,et al.  Metastases from carcinoma of mammary gland: An autopsy study , 1979, Journal of surgical oncology.

[142]  T. Martin,et al.  Breast Cancer Cells Interact with Osteoblasts to Support Osteoclast Formation* , 2022 .